191 related articles for article (PubMed ID: 20512604)
1. Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics.
Lu P; Bevan DR; Lewis SN; Hontecillas R; Bassaganya-Riera J
J Mol Model; 2011 Mar; 17(3):543-53. PubMed ID: 20512604
[TBL] [Abstract][Full Text] [Related]
2. Computational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2.
Lu P; Hontecillas R; Horne WT; Carbo A; Viladomiu M; Pedragosa M; Bevan DR; Lewis SN; Bassaganya-Riera J
PLoS One; 2012; 7(4):e34643. PubMed ID: 22509338
[TBL] [Abstract][Full Text] [Related]
3. Abscisic acid regulates inflammation via ligand-binding domain-independent activation of peroxisome proliferator-activated receptor gamma.
Bassaganya-Riera J; Guri AJ; Lu P; Climent M; Carbo A; Sobral BW; Horne WT; Lewis SN; Bevan DR; Hontecillas R
J Biol Chem; 2011 Jan; 286(4):2504-16. PubMed ID: 21088297
[TBL] [Abstract][Full Text] [Related]
4. Identification of a high affinity binding site for abscisic acid on human lanthionine synthetase component C-like protein 2.
Cichero E; Fresia C; Guida L; Booz V; Millo E; Scotti C; Iamele L; de Jonge H; Galante D; De Flora A; Sturla L; Vigliarolo T; Zocchi E; Fossa P
Int J Biochem Cell Biol; 2018 Apr; 97():52-61. PubMed ID: 29421190
[TBL] [Abstract][Full Text] [Related]
5. LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells.
Sturla L; Fresia C; Guida L; Bruzzone S; Scarfì S; Usai C; Fruscione F; Magnone M; Millo E; Basile G; Grozio A; Jacchetti E; Allegretti M; De Flora A; Zocchi E
J Biol Chem; 2009 Oct; 284(41):28045-28057. PubMed ID: 19667068
[TBL] [Abstract][Full Text] [Related]
6. Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes.
Lu P; Hontecillas R; Philipson CW; Bassaganya-Riera J
Curr Drug Targets; 2014 Jun; 15(6):565-72. PubMed ID: 24628287
[TBL] [Abstract][Full Text] [Related]
7. Binding of abscisic acid to human LANCL2.
Sturla L; Fresia C; Guida L; Grozio A; Vigliarolo T; Mannino E; Millo E; Bagnasco L; Bruzzone S; De Flora A; Zocchi E
Biochem Biophys Res Commun; 2011 Nov; 415(2):390-5. PubMed ID: 22037458
[TBL] [Abstract][Full Text] [Related]
8. Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.
Ma Y; Wang SQ; Xu WR; Wang RL; Chou KC
PLoS One; 2012; 7(6):e38546. PubMed ID: 22685582
[TBL] [Abstract][Full Text] [Related]
9. Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells.
Parajuli KR; Jung Y; Taichman RS
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38624012
[TBL] [Abstract][Full Text] [Related]
10. Multi-Targeted Molecular Docking, Pharmacokinetics, and Drug-Likeness Evaluation of Okra-Derived Ligand Abscisic Acid Targeting Signaling Proteins Involved in the Development of Diabetes.
Ashraf SA; Elkhalifa AEO; Mehmood K; Adnan M; Khan MA; Eltoum NE; Krishnan A; Baig MS
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641501
[No Abstract] [Full Text] [Related]
11. T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.
Li Y; Wang Z; Furukawa N; Escaron P; Weiszmann J; Lee G; Lindstrom M; Liu J; Liu X; Xu H; Plotnikova O; Prasad V; Walker N; Learned RM; Chen JL
J Biol Chem; 2008 Apr; 283(14):9168-76. PubMed ID: 18263587
[TBL] [Abstract][Full Text] [Related]
12. LANCL1 binds abscisic acid and stimulates glucose transport and mitochondrial respiration in muscle cells via the AMPK/PGC-1α/Sirt1 pathway.
Spinelli S; Begani G; Guida L; Magnone M; Galante D; D'Arrigo C; Scotti C; Iamele L; De Jonge H; Zocchi E; Sturla L
Mol Metab; 2021 Nov; 53():101263. PubMed ID: 34098144
[TBL] [Abstract][Full Text] [Related]
13. Novel ligands that target the mitochondrial membrane protein mitoNEET.
Bieganski RM; Yarmush ML
J Mol Graph Model; 2011 Jun; 29(7):965-73. PubMed ID: 21531159
[TBL] [Abstract][Full Text] [Related]
14. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action and medicinal applications of abscisic Acid.
Bassaganya-Riera J; Skoneczka J; Kingston DG; Krishnan A; Misyak SA; Guri AJ; Pereira A; Carter AB; Minorsky P; Tumarkin R; Hontecillas R
Curr Med Chem; 2010; 17(5):467-78. PubMed ID: 20015036
[TBL] [Abstract][Full Text] [Related]
16. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
[TBL] [Abstract][Full Text] [Related]
17. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
Gani OA
Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
[TBL] [Abstract][Full Text] [Related]
18. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
[TBL] [Abstract][Full Text] [Related]
19. INT131: a selective modulator of PPAR gamma.
Motani A; Wang Z; Weiszmann J; McGee LR; Lee G; Liu Q; Staunton J; Fang Z; Fuentes H; Lindstrom M; Liu J; Biermann DH; Jaen J; Walker NP; Learned RM; Chen JL; Li Y
J Mol Biol; 2009 Mar; 386(5):1301-11. PubMed ID: 19452630
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel peroxisome proliferator-activated receptor-gamma (PPARγ) agonists using molecular modeling method.
Gee VM; Wong FS; Ramachandran L; Sethi G; Kumar AP; Yap CW
J Comput Aided Mol Des; 2014 Nov; 28(11):1143-51. PubMed ID: 25168706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
